Sign Up Today and Learn More About BioCatch Stock
Invest in or calculate the value of your shares in BioCatch or other pre-IPO companies through EquityZen's platform.
About BioCatch Stock
Founded
2011
Total Funding
41.6M
Industries
Software, Artificial Intelligence, Data and Analytics
BioCatch offers a range of behavioral authentication and threat detection solutions for web and mobile applications. Available as a cloud-based solution, BioCatch collects and analyzes more than 2000 cognitive parameters to generate unique user profiles. Organizations use the platform to continuously authenticate users during their online sessions, protecting against cyber threats and fraudulent activity, such as account takeover and RAT-in-the-Browser (RitB), remote access, and automated accounting manipulation.
BioCatch Press Mentions
Stay in the know about the latest news on BioCatch
BioCatch finishes 2025 with best quarter in company history
prnewswire • Jan 30, 2026
BioCatch finishes 2025 with best quarter in company history
morningstar • Jan 29, 2026
BioCatch Executive Says Santander Survey Indicates UK Payment Regulations Must Change
crowdfundinsider • Dec 04, 2025
Regtech : BioCatch Connect 2.0 to Enable Fraud and Financial Crime Combatting Capabilities for FIs
crowdfundinsider • Nov 29, 2025
Real-time intelligence sharing reveals millions in attempted bank fraud
biometricupdate • Nov 28, 2025
Investors in BioCatch
Discover investors in BioCatch stock and explore their portfolio companies
BioCatch Management
Leadership team at BioCatch
Chief Executive Officer
Howard Edelstein
Co-Founder & Chief Technology Officer
Avi Turgeman
Join now and verify your accreditation status to gain access to:
- BioCatch Current Valuation
- BioCatch Stock Price
- BioCatch Management
- Available deals in BioCatch and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- BioCatch Cap Table and Funding History by Share Class and Liquidity Preferences
- BioCatch Revenue and Financials
- BioCatch Highlights
- BioCatch Business Model
- BioCatch Risk Factors
- BioCatch Research Report from SACRA Research
Trading BioCatch Stock
How to invest in BioCatch stock?
Accredited investors can buy pre-IPO stock in companies like BioCatch through EquityZen funds. These investments are made available by existing BioCatch shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell BioCatch stock?
Shareholders can sell their BioCatch stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
